James Bussel is an Oncology physician affiliated with Cornell University. OpenAlex indexes 770 publications with 38,114 citations (h-index 95); ClinicalTrials.gov lists 18 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 1% of Pediatric Hematology-Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
525 E 68th St # P-695
New York, NY 100214870
Telephone
212-746-3400Registry record last updated 14 Sept 2011.
Clinical trials
- Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia
Sponsor: Weill Medical College of Cornell University
- A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone
Sponsor: Weill Medical College of Cornell University
- A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013
Sponsor: Weill Medical College of Cornell University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20255 payments
- SOBI, INCProgram year202411 payments$19,183openpaymentsdata.cms.gov ↗
- Grifols USA, LLCProgram year20245 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
4 NIH research awards on record, funded 1987–2014 per NIH RePORTER. The latest:
- Determining Optimum Medical Therapy for ITP
Weill Medical Coll of Cornell Univ
FY2014$412,679U34HL115015 - Determining Optimum Medical Therapy for ITP
Weill Medical Coll of Cornell Univ
FY2013$417,895U34HL115015 - Novel Therapies in Hemostasis and Transfusion
Weill Medical Coll of Cornell Univ
FY2012$183,750U01HL072196
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Thrombocytopenia following Pfizer and Moderna <scp>SARS‐CoV</scp>‐2 vaccination
American Journal of Hematology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Devereux, MD
Cornell University
Thomas Walsh, MD
Cornell University
Cora Sternberg, MD
Cornell University
George Alexopoulos, MD
Cornell University
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”